Related Experiment Video
Updated: Jan 27, 2026

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
ADS-J1 disaggregates semen-derived amyloid fibrils
Jinqing Li1, Zichao Yang1, Han Liu1
1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
Abstract:
Semen-derived amyloid fibrils, comprising SEVI (semen-derived enhancer of viral infection) fibrils and SEM1 fibrils, could remarkably enhance HIV-1 sexual transmission and thus are potential targets for the development of an effective microbicide. Previously, we found that ADS-J1, apart from being an HIV-1 entry inhibitor, could also potently inhibit seminal amyloid fibrillization and block fibril-mediated enhancement of viral infection. However, the remodeling effects of ADS-J1 on mature seminal fibrils were unexplored. Herein, we investigated the capacity of ADS-J1 to disassemble seminal fibrils and the potential mode of action by applying several biophysical and biochemical measurements, combined with molecular dynamic (MD) simulations. We found that ADS-J1 effectively remodeled SEVI, SEM186-107 fibrils and endogenous seminal fibrils. Unlike epigallocatechin gallate (EGCG), a universal amyloid fibril breaker, ADS-J1 disaggregated SEVI fibrils into monomeric peptides, which was independent of oxidation reaction. MD simulations revealed that ADS-J1 displayed strong binding potency to the full-length PAP248-286 via electrostatic interactions, hydrophobic interactions and hydrogen bonds. ADS-J1 might initially bind to the fibrillar surface and then occupy the amyloid core, which eventually lead to fibril disassembly. Furthermore, the binding of ADS-J1 with PAP248-286 might induce conformational changes of PAP248-286 Disassembled PAP248-286 might not be favorable to re-aggregate into fibrils. ADS-J1 also exerts abilities to remodel a panel of amyloid fibrils, including Aβ1-42, hIAPP1-37 and EP2 fibrils. ADS-J1 displays promising potential to be a combination microbicide and an effective lead-product to treat amyloidogenic diseases.
Insights
ADS-J1 effectively disassembles semen-derived amyloid fibrils (SEVI) and other amyloid structures. This compound shows potential as a dual-action microbicide and a therapeutic for amyloid diseases.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Semen-derived amyloid fibrils (SEVI) enhance HIV-1 sexual transmission.
- ADS-J1 inhibits HIV-1 entry and seminal amyloid fibril formation.
- The effect of ADS-J1 on mature seminal fibrils was previously unknown.
Purpose of the Study:
- To investigate ADS-J1's capacity to disassemble seminal amyloid fibrils.
- To elucidate the mechanism of action for ADS-J1's fibril remodeling.
- To explore ADS-J1's potential as a microbicide and therapeutic for amyloid diseases.
Main Methods:
- Biophysical and biochemical measurements.
- Molecular dynamic (MD) simulations.
- Analysis of fibril remodeling of SEVI, SEM1, and endogenous seminal fibrils.
Main Results:
- ADS-J1 effectively remodeled SEVI, SEM186-107, and endogenous seminal fibrils.
- ADS-J1 disaggregated SEVI fibrils into monomers, independent of oxidation.
- MD simulations showed ADS-J1 binds strongly to PAP248-286, leading to disassembly and preventing re-aggregation.
Conclusions:
- ADS-J1 disassembles seminal amyloid fibrils and other amyloid structures like Aβ1-42.
- ADS-J1's mechanism involves binding to the fibril surface and core, inducing conformational changes.
- ADS-J1 holds promise as a combination microbicide and a lead compound for amyloidogenic diseases.
More Related Videos
09:00Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
09:43Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli
Published on: December 19, 2015
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Sperm Structure and Semen Composition
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Measurement: Derived Units
First Derivative Test: Problem Solving